News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
577,828 Results
Type
Article (43970)
Company Profile (212)
Press Release (533637)
Multimedia
Podcasts (114)
Webinars (13)
Section
Business (164347)
Career Advice (2762)
Deals (29113)
Drug Delivery (102)
Drug Development (64303)
Employer Resources (175)
FDA (13574)
Job Trends (12065)
News (276160)
Policy (25646)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2303)
Academic (1)
Accelerated approval (31)
Adcomms (21)
Allergies (104)
Alliances (40760)
ALS (142)
Alzheimer's disease (1406)
Antibody-drug conjugate (ADC) (283)
Approvals (13771)
Artificial intelligence (488)
Autoimmune disease (125)
Automation (33)
Bankruptcy (247)
Best Places to Work (9589)
BIOSECURE Act (20)
Biosimilars (140)
Biotechnology (156)
Bladder cancer (140)
Brain cancer (52)
Breast cancer (543)
Cancer (4188)
Cardiovascular disease (340)
Career advice (2326)
Career pathing (39)
CAR-T (256)
CDC (37)
Celiac Disease (2)
Cell therapy (706)
Cervical cancer (35)
Clinical research (54563)
Collaboration (1524)
Company closure (1)
Compensation (686)
Complete response letters (49)
COVID-19 (2380)
CRISPR (99)
C-suite (747)
Cystic fibrosis (139)
Data (5373)
Decentralized trials (1)
Denatured (27)
Depression (117)
Diabetes (396)
Diagnostics (6004)
Digital health (35)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (231)
Drug pricing (131)
Drug shortages (19)
Duchenne muscular dystrophy (228)
Earnings (70370)
Editorial (53)
Employer branding (22)
Employer resources (156)
Events (87431)
Executive appointments (832)
FDA (16191)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (18)
Funding (1246)
Gene editing (218)
Generative AI (48)
Gene therapy (672)
GLP-1 (794)
Government (3516)
Grass and pollen (6)
Guidances (371)
Healthcare (15483)
HIV (57)
Huntington's disease (45)
IgA nephropathy (70)
Immunology and inflammation (205)
Immuno-oncology (55)
Indications (82)
Infectious disease (2613)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (98)
Intellectual property (193)
Interviews (532)
IPO (13583)
IRA (31)
Job creations (2829)
Job search strategy (1889)
JPM (60)
Kidney cancer (16)
Labor market (70)
Layoffs (494)
Leadership (36)
Legal (6437)
Liver cancer (81)
Longevity (10)
Lung cancer (578)
Lymphoma (338)
Machine learning (40)
Management (62)
Manufacturing (682)
MASH (124)
Medical device (10224)
Medtech (10260)
Mergers & acquisitions (16440)
Metabolic disorders (1016)
Multiple sclerosis (123)
NASH (14)
Neurodegenerative disease (279)
Neuropsychiatric disorders (75)
Neuroscience (2456)
Neurotech (1)
NextGen: Class of 2026 (5382)
Non-profit (3811)
Now hiring (35)
Obesity (481)
Opinion (301)
Ovarian cancer (131)
Pain (153)
Pancreatic cancer (186)
Parkinson's disease (234)
Partnered (30)
Patents (373)
Patient recruitment (387)
Peanut (37)
People (49075)
Pharmaceutical (34)
Pharmacy benefit managers (23)
Phase 1 (17196)
Phase 2 (23867)
Phase 3 (18575)
Pipeline (4583)
Policy (232)
Postmarket research (1933)
Preclinical (7295)
Press Release (72)
Prostate cancer (201)
Psychedelics (38)
Radiopharmaceuticals (253)
Rare diseases (825)
Real estate (4591)
Recruiting (71)
Regulatory (19337)
Reports (42)
Research institute (2143)
Resumes & cover letters (467)
Rett syndrome (27)
RNA editing (19)
RSV (67)
Schizophrenia (127)
Series A (216)
Series B (160)
Service/supplier (8)
Sickle cell disease (102)
Special edition (19)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (3044)
State (1)
Stomach cancer (17)
Supply chain (81)
Tariffs (57)
The Weekly (86)
Vaccines (927)
Venture capital (77)
Weight loss (310)
Women's health (63)
Worklife (20)
Date
Today (13)
Last 7 days (483)
Last 30 days (1893)
Last 365 days (25388)
2026 (2383)
2025 (25697)
2024 (29546)
2023 (33674)
2022 (44440)
2021 (47686)
2020 (44823)
2019 (37745)
2018 (28609)
2017 (26840)
2016 (25770)
2015 (30349)
2014 (23172)
2013 (25300)
2012 (20607)
2011 (21069)
2010 (19487)
Location
Africa (781)
Alabama (44)
Alaska (6)
Arizona (180)
Arkansas (8)
Asia (33582)
Australia (5784)
California (9288)
Canada (2775)
China (909)
Colorado (375)
Connecticut (400)
Delaware (248)
Europe (82176)
Florida (1330)
Georgia (285)
Hawaii (3)
Idaho (45)
Illinois (659)
India (60)
Indiana (383)
Iowa (21)
Japan (402)
Kansas (108)
Kentucky (35)
Louisiana (23)
Maine (72)
Maryland (1147)
Massachusetts (6836)
Michigan (301)
Minnesota (425)
Mississippi (5)
Missouri (109)
Montana (28)
Nebraska (20)
Nevada (107)
New Hampshire (58)
New Jersey (2645)
New Mexico (25)
New York (2370)
North Carolina (1140)
North Dakota (9)
Northern California (4609)
Ohio (266)
Oklahoma (12)
Oregon (28)
Pennsylvania (1745)
Puerto Rico (16)
Rhode Island (37)
South America (1035)
South Carolina (36)
South Dakota (1)
Southern California (3549)
Tennessee (129)
Texas (1376)
United States (32613)
Utah (279)
Vermont (1)
Virginia (222)
Washington D.C. (64)
Washington State (798)
West Virginia (4)
Wisconsin (98)
Wyoming (2)
577,828 Results for "ge corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB
February 5, 2026
·
2 min read
Press Releases
GE HealthCare reports fourth quarter and full year 2025 financial results
February 5, 2026
·
20 min read
Press Releases
GE HealthCare management to present at upcoming January 2026 investor conference
December 29, 2025
·
1 min read
Press Releases
GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026
January 5, 2026
·
1 min read
Press Releases
Enterra Medical Introduces the new, FDA approved Enterra ReliaStim® as the Next Step Toward the Future of GES Therapy
January 13, 2026
·
2 min read
Press Releases
GE HealthCare announces cash dividend for fourth quarter of 2025
November 25, 2025
·
1 min read
Press Releases
GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
February 2, 2026
·
6 min read
Press Releases
GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care
December 4, 2025
·
5 min read
Press Releases
GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
November 27, 2025
·
8 min read
Press Releases
GE HealthCare to announce third quarter 2025 results on October 29, 2025
October 2, 2025
·
1 min read
1 of 57,783
Next
